Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

ose excursion following an oral glucose load or a meal. In studies with healthy subjects, JANUVIA did not lower blood glucose or cause hypoglycemia. Cardiac Electrophysiology In a randomized, placebo-controlled crossover study, 79 healthy subjects were administered a single oral dose of JANUVIA 100 mg, JANUVIA 800 mg (8 times the recommended dose), and placebo. At the recommended dose of 100 mg, there was no effect on the QTc interval obtained at the peak plasma concentration, or at any other time during the study. Following the 800 mg dose, the maximum increase in the placebo-corrected mean change in QTc from baseline was observed at 3 hours postdose and was 8.0 msec. This increase is not considered to be clinically significant. At the 800 mg dose, peak sitagliptin plasma concentrations were approximately 11-fold higher than the peak concentrations following a 100 mg dose. In patients with type 2 diabetes administered JANUVIA 100 mg (N=81) or JANUVIA 200 mg (N=63) daily, there were no meaningful changes in QTc interval based on ECG data obtained at the time of expected peak plasma concentration. 12.3 Pharmacokinetics The pharmacokinetics of sitagliptin has been extensively characterized in healthy subjects and patients with type 2 diabetes. After oral administration of a 100 mg dose to healthy subjects, sitagliptin was rapidly absorbed, with peak plasma concentrations (median Tmax) occurring 1 to 4 hours postdose. Plasma AUC of sitagliptin increased in a dose-proportional manner. Following a single oral 100 mg dose to healthy volunteers, mean plasma AUC of sitagliptin was 8.52 ?M-hr, Cmax was 950 nM, and apparent terminal half-life (t1/2) was 12.4 hours. Plasma AUC of sitagliptin increased approximately 14% following 100 mg doses at steady-state compared to the first dose. The intra-subject and inter-subject coefficients of variation for sitagliptin AUC were small (5.8% and 15.1%). The pharmacokinetics o
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
(Date:9/29/2014)... 2014 Dynatronics Corporation (NASDAQ: ... investors today at 2:00 p.m. ET to discuss ... June 30, 2014.  The corrected call-in number for ... Dynatronics manufactures, markets and distributes advanced-technology medical ... and rehabilitation equipment for the physical therapy, sports ...
(Date:9/29/2014)... BOGOTA, Colombia , Sept. 29, 2014 /PRNewswire/ ... has announced a promising new drug treatment: ... 3-bromopyruvate (3-BrPA) that has already proven successful at ... medical researchers behind this novel treatment are optimistic ... patients who have exhausted current therapeutic avenues. ...
Breaking Medicine Technology:Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... Reportlinker.com announces that a new ... its catalogue: External ... Russia, India, China, South Africa) to ... External Defibrillator Market ...
... Orthopedic Group, Inc. today announced the appointment of Vinit ... immediately.  Mr. Asar joined the company in December 2008 ... nearly 20 years of global business operations experience in ... his new position, Mr. Asar will continue to lead ...
Cached Medicine Technology:External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 2Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 3
(Date:9/30/2014)... 2014 In honor of National Breast ... and their courageous battles, Incredible Veins, Body & Skin ... PicoSure® by Cynosure. , “For cancer patients who ... is applied on their skin to accurately aim the ... “For many survivors, they decide to have their tattoo ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 In ... well as better data capture and management functions ... ClinCapture electronic data capture (EDC) system. ClinCapture offers ... ability to easily manage clinical trial data and ... cement Synergy’s position as the leading clinical research ...
(Date:9/30/2014)... high-dose vitamin D3 compared with placebo did not reduce ... of stay, hospital mortality, or the risk of death ... who were critically ill, according to a study published ... early online to coincide with its presentation at the ... , A high prevalence of low vitamin D levels ...
(Date:9/30/2014)... Delhi, India (PRWEB) September 30, 2014 RBS ... reputation management service named ‘Remove Your Name’. , The ... being asked reason behind giving the service this odd name, ... there is nothing odd in this name. We have named ... as well as organizations to get rid of all those ...
(Date:9/30/2014)... Massachusetts (PRWEB) September 30, 2014 ... Wingate of East Longmeadow facility has officially announced ... Ventilator Program that combines advanced medical technology ... program is one of the only non-hospital options ... of care. The primary focus of this ...
Breaking Medicine News(10 mins):Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 2Health News:Wingate Healthcare Announces New Ventilator Care Program at East Longmeadow Facility 3
... activities and may make men smarter by enabling them ... study.// ,Researchers studied the effects of fatherhood ... that spend 70 percent of their time caring for ... time, according to new research by Princeton University psychologist ...
... people are hit harder by hangover while teenagers have a ... ,US psychologist Elena Varlinskaya and other researchers studied the effects ... teenagers and adults. , ,The rats - chosen because ... with alcohol and their movements monitored, reported the online edition ...
... personnel returning from vacation, the Central Reserve Police Force (CRPF) ... ,"We have found that over 80 percent of ... personnel who had returned from leave," said a CRPF official ... official added that the trend was mostly sighted in Delhi, ...
... pain and disc disorder now have a reason to ... results than conventional// surgery. ,Ozonucleolysis, as the ... western countries, according to senior doctors who are here ... ozone discectomy for curing spinal injury is a better ...
... in Chennai attracted a visitor from the Safari country ... osteoarthritis of both knees underwent bilateral// knee replacements here ... Orthopedic surgeon remarked that this was the first time ... for bilateral knee replacements. His son, a UK based ...
... research findings show men have fewer long-term gastrointestinal ... with three-dimensional// conformal radiation therapy (3D CRT) for ... radiation used in the IMRT group. These and ... presented today at the 48th Annual Meeting of ...
Cached Medicine News:Health News:Older People Get Worse Hangovers 2Health News:CRPF To Issue Contraceptives To Fight AIDS 2Health News:Ozone Treatment - A Good Alternative For Spinal Injury 2Health News:IMRT Versus 3D CRT For Prostate Cancer, New Long-Term Data Assesses Side Effects 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: